Pharmacological characterization of emerging hexahydrocannabinol-derived semi-synthetic cannabinoids at the cannabinoid type 1 receptor using a β-arrestin2 recruitment assay
Marjolein Coulier, Alayna Jones, Katleen Van Uytfanghe, Robert B. Laprairie, Marthe M. Vandeputte, Christophe P. Stove
Springer Nature ·
2026-11-12
· DOI 10.1007/s00204-026-04632-4
The publisher did not provide an abstract — full text is available via the link below.
Marjolein Coulier, Alayna Jones, Katleen Van Uytfanghe, Robert B. Laprairie, Marthe M. Vandeputte, Christophe P. Stove. Pharmacological characterization of emerging hexahydrocannabinol-derived semi-synthetic cannabinoids at the cannabinoid type 1 receptor using a β-arrestin2 recruitment assay. // Archives of Toxicology. – 2026. – DOI: 10.1007/s00204-026-04632-4. – URL: https://doi.org/10.1007/s00204-026-04632-4
Marjolein Coulier, Alayna Jones, Katleen Van Uytfanghe, Robert B. Laprairie, Marthe M. Vandeputte, & Christophe P. Stove (2026). Pharmacological characterization of emerging hexahydrocannabinol-derived semi-synthetic cannabinoids at the cannabinoid type 1 receptor using a β-arrestin2 recruitment assay. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04632-4
Marjolein Coulier, et al. “Pharmacological characterization of emerging hexahydrocannabinol-derived semi-synthetic cannabinoids at the cannabinoid type 1 receptor using a β-arrestin2 recruitment assay.” Archives of Toxicology, 2026. doi:10.1007/s00204-026-04632-4.
@article{Coulier2026,
title = {Pharmacological characterization of emerging hexahydrocannabinol-derived semi-synthetic cannabinoids at the cannabinoid type 1 receptor using a β-arrestin2 recruitment assay},
author = {Coulier, Marjolein and Jones, Alayna and Uytfanghe, Katleen Van and Laprairie, Robert B. and Vandeputte, Marthe M. and Stove, Christophe P.},
journal = {Archives of Toxicology},
year = {2026},
doi = {10.1007/s00204-026-04632-4},
url = {https://doi.org/10.1007/s00204-026-04632-4}
}